Articles

Results 6 to 10 of 25


Key Considerations for Reshoring U.S. Drug Manufacturing

USA - October 13 2020 This Diagnosing Health Care Episode dives into the key business operations and legal considerations for reshoring active pharmaceutical ingredient…

Delia A. Deschaine, Neil P. Di Spirito

FDA leverages patient-reported information to monitor drug safety

USA - July 24 2015 FDA has recently partnered with PatientsLikeMe, an online patient networking forum, to leverage patient-reported information to bolster its drug…

Physically securing electronic PHI in a telehealth environment

USA - April 16 2013 As the technologies used to deliver telehealth services become more complex, telehealth providers as well as other HIPAA "covered entities" have an…

Ross K. Friedberg

OIG Permits Manufacturer of Personalized Medicine Drug to Cover Patients’ Travel, Lodging, and Other Expenses

USA - January 29 2020 On January 21, 2020, the Office of Inspector General for the U.S. Department of Health and Human Services (“OIG”) published Advisory Opinion 20-02…

Jennifer E. Michael

Building Compliance Programs for AI Tools

USA - March 19 2021 Artificial Intelligence (“AI”) applications are powerful tools that already have been deployed by companies to improve business performance across…

Anjali N.C. Downs